G40.2
Conditions
Interventions
Group 1: Participants will wear an Empatica E4 or EmbracePlus (wearable sensor) device for 12-18h a day for the entire duration of the study (6 months). They will perform cognitive tests and speech ta
Sponsors
King's College
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Able to give informed consent for participation 2. Diagnosis of epilepsy 3. Between the ages of 18 – 70 4. Minimum average seizure frequency of 2 seizures/month 5. Willing and able to complete self-reported assessments via smartphone 6. Fluent in German or English and able to read/write German or English 7. Willing to continuously wear the study smartwatch 8. Existing ownership of Android smartphone (or willingness to use an Android smartphone, which will be provided, as their only smartphone) 9. Existing ownership of, or possibility to connect to, a wi-fi connection on a daily basis
Exclusion criteria
Exclusion criteria: 1. Established diagnosis of psychogenic non-epileptic attacks (dissociative seizures) as the only seizure type 2. Frequent vigorous involuntary movements (e.g. chorea, athetosis) or frequent parasomnias with major motor components (e.g. sleep walking, night terrors) 3. Inability to comply with the trial procedure, such as cognitive or behavioural problems 4. Inability to give informed consent 5. Unwillingness to use an Android smartphone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Assessment of the utility and patients’ acceptability of multiparametric remote-measurement technology (RMT) in clinical populations with epilepsy. 2. Assessment of how patient-marked seizure events correspond to RMT data collected from the RMT in the community/ambulatory setting | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Sensitivity of the device as compared to patient self-reporting (diary) for different seizure types 2. False alarm rate (non-seizure events) of the device 3. Identification of variables influencing seizure occurrence | — |
Countries
Germany, United Kingdom
Contacts
Public ContactAndreas Schulze-Bonhage
Universitätsklinikum Freiburg, Epilepsiezentrum
Outcome results
None listed